EUROPE BOTULINUM TOXIN MARKET 2021-2028

 

 

TABLE OF CONTENTS

 

1.     EUROPE BOTULINUM TOXIN MARKET – SUMMARY   

2.     INDUSTRY OUTLOOK

1.1. KEY INSIGHTS     

1.1.1.    SURGE IN DISPOSABLE INCOME       

1.1.2.    GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT  

1.1.3.    DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

1.1. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY 

1.2. PORTER’S FIVE FORCES ANALYSIS 

1.1.1.    THREAT OF NEW ENTRANTS   

1.1.2.    THREAT OF SUBSTITUTE         

1.1.3.    BARGAINING POWER OF SUPPLIERS

1.1.4.    BARGAINING POWER OF BUYERS     

1.1.5.    THREAT OF COMPETITIVE RIVALRY  

1.1. MARKET ATTRACTIVENESS MATRIX

1.2. VENDOR SCORECARD  

1.3. KEY MARKET STRATEGIES     

1.1.1.    NEW PRODUCT LAUNCHES     

1.1. MARKET DRIVERS         

1.1.1.    INCREASING DEMAND FOR AESTHETIC PROCEDURES 

1.1.2.    EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS        

1.1. MARKET RETSRAINTS   

1.1.1.    ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN  

1.1.2.    LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES 

1.1.3.    LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS   

1.1. MARKET OPPORTUNITIES      

1.1.1.    INCREASING AGING POPULATION    

1.1.2.    RISE IN MEDICAL TOURISM     

2.     EUROPE BOTULINUM TOXIN MARKET – BY TYPE      

1.1. TYPE A      

1.2. TYPE B      

2.     EUROPE BOTULINUM TOXIN MARKET – BY APPLICATION   

1.1. COSMETIC APPLICATIONS      

1.1.1.    GLABELLAR LINES         

1.1.2.    LATERAL CANTHAL LINES (CROW’S FEET) 

1.1.3.    FOREHEAD LINES

1.1.4.    OTHER COSMETIC APPLICATIONS    

1.1. NON-COSMETIC APPLICATIONS       

1.1.1.    DYSTONIA  

1.1.2.    CHRONIC MIGRAINE      

1.1.3.    OPHTHALMOLOGIC DISORDERS       

1.1.4.    OTHER NON-COSMETIC APPLICATIONS     

2.     EUROPE BOTULINUM TOXIN MARKET – BY END-USER       

1.1. HOSPITALS

1.2. CLINICS AND OTHERS  

2.     EUROPE BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK          

1.1. COUNTRY ANALYSIS     

1.1.1.    UNITED KINGDOM

1.1.2.    GERMANY  

1.1.3.    FRANCE      

1.1.4.    SPAIN         

1.1.5.    ITALY

1.1.6.    RUSSIA       

1.1.7.    REST OF EUROPE          

2.     COMPETITIVE LANDSCAPE 

1.1. ABBVIE INC

1.2. EVOLUS INC

1.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)     

1.4. HUGEL INC

1.5. IPSEN PHARMA   

1.6. MERZ PHARMA    

1.7. MEDYTOX INC

1.8. REVANCE THERAPEUTICS INC

1.9. US WORLDMEDS LLC    

2.     METHODOLOGY & SCOPE  

1.1. RESEARCH SCOPE & DELIVERABLES        

1.2. SOURCES OF DATA      

1.3. RESEARCH METHODOLOGY  

 

 

LIST OF TABLES

 

TABLE 1: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

 

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028

FIGURE 3: EUROPE BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: EUROPE BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028

FIGURE 6: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028

FIGURE 17: EUROPE BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED KINGDOM BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: GERMANY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: FRANCE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: SPAIN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: ITALY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: RUSSIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: REST OF EUROPE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

 

Triton’s report has determined the botulinum toxin market in Europe to progress at a CAGR of 5.58% over the forecasting duration 2021-2028. The United Kingdom, Germany, France, Spain, Italy, Russia, and Rest of Europe together constitute the market in this region.

The growth in the population and the rise in people’s education & financial levels have enhanced the demand for healthcare services in Spain. As per estimates, close to 247,223 non-invasive aesthetic procedures were performed in the country in 2016. Out of these, 81,833 were botulinum toxin-based procedures. Botulinum toxin-based products (Botox, Xeomin, and Dysport) are gaining popularity in Spain, and it is expected to increase even more in the future. The increase in collaborations/agreements between companies and the growing focus of bigger players on product launches are expected to aid the growth of the Spanish market in the coming years.

Italy is the fourth-largest market for cosmetic and aesthetic procedures in Europe. 1 out of every 10 patients applying for cosmetic surgery in the country is a tourist. Owing to the top-notch medical facilities and services provided here, people from neighboring and other countries, mainly those from Switzerland, Romania, and Russia, flock to Italy for cosmetic treatments. In 2018, around 542,752 non-invasive cosmetic procedures were performed in the country, with 181,472 being botulinum toxin-based procedures. All these factors are expected to fuel the growth of the Italian botulinum toxin market in the projected phase.

 

 

COMPETITIVE OUTLOOK

 

Some of the established names in the botulinum toxin market are US WorldMeds LLC, Revance Therapeutics Inc, Galderma Pharma SA (Acquired by EQT), Merz Pharma, and Ipsen Pharma.

 

Get more insights into the Europe Botulinum Toxin Market:

 

https://www.tritonmarketresearch.com/reports/europe-botulinum-toxin-market

 

 

SEGMENTATION

 

1.     ABBVIE INC     

2.     EVOLUS INC

3.     GALDERMA PHARMA SA (ACQUIRED BY EQT) 

4.     HUGEL INC

5.     IPSEN PHARMA         

6.     MERZ PHARMA

7.     MEDYTOX INC

8.     REVANCE THERAPEUTICS INC

9.     US WORLDMEDS LLC

 

 

Comments

Post a Comment

Popular posts from this blog

NORTH AMERICA BIOCHAR MARKET 2022-2028

    TABLE OF CONTENTS 1. NORTH AMERICA BIOCHAR MARKET - SUMMARY 2. INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON BIOCHAR MARKET 2.2. KEY INSIGHTS 2.2.1. PYROLYSIS IS THE MOST COMMON TECHNIQUE FOR BIOCHAR PRODUCTION 2.2.2. AGRICULTURE DOMINATES THE APPLICATION SEGMENT 2.2.3. GROWING NEED TO AVOID BIOCHAR LOSS DURING APPLICATION AND TRANSPORTATION 2.3. PORTER’S FIVE FORCES ANALYSIS 2.3.1. THREAT OF NEW ENTRANTS 2.3.2. THREAT OF SUBSTITUTES 2.3.3. BARGAINING POWER OF BUYERS 2.3.4. BARGAINING POWER OF SUPPLIERS 2.3.5. THREAT OF COMPETITIVE RIVALRY 2.4. KEY IMPACT ANALYSIS 2.5. MARKET ATTRACTIVENESS INDEX 2.6. VENDOR SCORECARD 2.7. INDUSTRY COMPONENTS 2.8. REGULATORY FRAMEWORK 2.9. KEY MARKET STRATEGIES 2.9.1. PRODUCT LAUNCHES & DEVELOPMENTS 2.9.2. PARTNERSHIPS & AGREEMENTS 2.10. MARKET DRIVERS 2.10.1. FAVORABLE INITIATIVES 2.10.2. AVAILABILITY OF CHEAP FEEDSTOCK 2.10.3. ABILITY OF BIOCHAR TO SEQUESTER CARBON 2.10.4. RELIA...
Read more

ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026

    TABLE OF CONTENT 1.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET –SUMMARY 1.1. COUNTRY SNAPSHOT 1.2. MARKET SIZE & FORECAST 1.3. MARKET DRIVING ASPECTS 1.4. MARKET RESTRAINING ASPECTS 1.5. KEY PLAYERS 2.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET OUTLOOK 2.1. IMPACT OF COVID-19 ON ITALY ALCOHOLIC RTDS MARKET 2.2. PESTLE ANALYSIS 2.2.1.     POLITICAL 2.2.2.     ECONOMICAL 2.2.3.     SOCIAL 2.2.4.     TECHNOLOGICAL 2.2.5.     LEGAL 2.2.6.     ENVIRONMENTAL 2.3. MARKET ATTRACTIVENESS INDEX 2.4. MARKET SHARE ANALYSIS OF KEY PLAYERS 2.5. BRAND SHARE ANALYSIS 3.      ITALY ALCOHOLIC RTD MARKET SEGMENTATION - BY RTD TYPE (IN TERMS OF VALUE: $ MILLION & IN TERMS OF VOLUME: MILLION LITRES) 3.1. SPIRIT-BASED RTDS 3.2. WINE-BASED RTDS 4.    ...
Read more

GLOBAL ENTERPRISE RESOURCE PLANNING MARKET 2022-2028

    TABLE OF CONTENTS   1.      GLOBAL ENTERPRISE RESOURCE PLANNING MARKET - SUMMARY 2.      INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON ENTERPRISE RESOURCE PLANNING MARKET 2.2. PARENT MARKET ANALYSIS: ENTERPRISE APPLICATION MARKET 2.3. TIMELINE OF ENTERPRISE RESOURCE PLANNING (ERP) 2.4. KEY INSIGHTS 2.4.1.     EMERGENCE OF CLOUD ERP 2.4.2.     SOCIAL NETWORKING IS GAINING IMPORTANCE AMONG ERP MERCHANTS 2.4.3.     INTEGRATED ERP IS ONE OF THE PROMINENT EMERGING TRENDS 2.4.4.     ACQUISITION HAS EMERGED AS A PRIMARY GROWTH STRATEGY 2.5. PORTER’S FIVE FORCES ANALYSIS 2.5.1.     THREAT OF NEW ENTRANTS 2.5.2.     THREAT OF SUBSTITUTES 2.5.3.     BARGAINING POWER OF BUYERS 2.5.4.     BARGAINING POWER OF SUPPLIERS 2.5.5.     THREAT OF COMPETITIVE RIVALRY 2.6. KEY...
Read more